Purchases and Sales Made in Q3 2023 in Syndax Pharmaceuticals Inc (SNDX)
This table provides information about the institutional ownership of Syndax Pharmaceuticals Inc (SNDX) during Q3 2023. The information is specifically focused on institutions that hold shares of Syndax Pharmaceuticals Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 31, 2023
Q3 2023
|
Jennison Associates LLC
|
SELL
|
- |
-174K- 6.91% |
$2.53M - $3.79M
|
2.35M
$33.1M
|
|
|
Oct 31, 2023
Q3 2023
|
Panagora Asset Management Inc
Boston, MA |
SELL
|
- |
-176K- 65.74% |
$2.55M - $3.82M
|
91.5K
$1.29M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-188KClosed |
$2.73M - $4.1M
|
0
$0
|
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-488K- 82.15% |
$7.09M - $10.6M
|
106K
$1.49M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-553K- 13.32% |
$8.04M - $12M
|
3.6M
$50.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-578K- 94.44% |
$8.4M - $12.6M
|
34.1K
$480K
|
|
|
Nov 14, 2023
Q3 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.25M- 49.25% |
$18.1M - $27.1M
|
1.28M
$18.1M
|
|
|
Nov 14, 2023
Q3 2023
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-3.11M- 83.82% |
$45.1M - $67.7M
|
600K
$8.45M
|